Trials / Completed
CompletedNCT02008747
Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.
Effects of Prophylactic Administration of Magnesium Sulfate on the Incidence of Atrial Fibrillation and Chronic Neuropathic Pain After Thoracotomy for Lung Resection.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Dr. Horst Schmidt Klinik GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Atrial fibrillation and chronic neuropathic pain are adverse events occurring after posterolateral thoracotomy for lung resection. The continuous application of magnesium sulphate may have a prophylactic effect. The investigators record the incidence of atrial fibrillation during a seven day period after thoracotomy as well as the incidence of chronic neuropathic pain during a three months period, comparing one group with a continuous application of magnesium sulphate against one group without magnesium sulphate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium sulphate | Continuous application of magnesium sulphate applied 40 mg/kg ideal body weight by bolus before the operation started, followed by a continuous infusion of 10 mg/kg ideal body weight/h for 24 hours |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-02-01
- Completion
- 2012-05-01
- First posted
- 2013-12-11
- Last updated
- 2013-12-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02008747. Inclusion in this directory is not an endorsement.